<DOC>
	<DOCNO>NCT02650830</DOCNO>
	<brief_summary>`` The goal work critically test hypothesis exist different profile bile acid ( BAs ) patient type 2 diabetes mellitus ( T2DM ) compare normal control . Through confirmation different profile BAs T2DM , investigator suggest modulation specific bile acid new possible treatment target patient T2DM . Investigator also expect specific BAs signature use screen T2DM hyperglycemia . In addition , investigator evaluate association BA species serum total glucagon like peptide-1 ( GLP-1 ) fibroblast growth factor-19 ( FGF-19 ) concentration determine specific BAs profile relate total GLP-1 FGF-19 concentration serum . Investigatr also evaluate correlation BA species metabolic profile oxidative stress marker find possible role BA component glucose metabolism .</brief_summary>
	<brief_title>Seum Bile Acid Profile Type 2 Diabetes Association Between Bile Cid Profile Adipokine Oxidative Stress</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>1. prediabetes 1. define accord ADA guideline ( prediabetes definition ) FPG 100 mg/dL ( 5.6 mmol/L ) 125 mg/dL ( 6.9 mmol/L ) ( IFG ) 2h PG 75g OGTT 140 mg/dL ( 7.8 mmol/L ) 199 mg/dL ( 11.0 mmol/L ) ( IGT ) A1C 5.76.4 % ( 3946 mmol/mol ) 2. type 2 diabetes 1. define accord ADA guideline ( DM definition ) FPG ≥126 mg/dL ( 7.0 mmol/L ) 2h PG ≥200 mg/dL ( 11.1 mmol/L ) 75g OGTT A1C ≥6.5 % ( 48 mmol/mol ) In patient classic symptom hyperglycemia hyperglycemic crisis , random plasma glucose ≥200 mg/dL ( 11.1 mmol/L ) 2. take antidiabetic medication 3 . Normal control 1. include group 2. take medication relate diabetes dyslipidemia 3 . BMI &lt; 25kg/m2 1. subject refuse agree inform consent 2. subject organtransplantation 3. pregnant woman 4. type 1 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>prediabetes</keyword>
	<keyword>bile acid profile</keyword>
	<keyword>GLP-1</keyword>
	<keyword>FGF-19</keyword>
</DOC>